Apellis Pharmaceuticals, Inc.
APLS News Today: Stay Updated with the Latest Apellis Pharmaceuticals, Inc. News in Real Time
Find APLS news now at Meyka AI. Stay informed with the latest Apellis Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.
0Q3.DE Beyond Meat XETRA earnings after close 31 Mar 2026: cash burn in focus
0Q3.DE stock moved after Beyond Meat earnings on 31 Mar 2026; focus on cash, margins and a EUR 0.63 model forecast
BofA Maintains Neutral, Cowen Maintains Hold on Freshpet (FRPT) March 2026
FRPT analyst rating update: BofA and Cowen maintained ratings on Freshpet on March 17, 2026
PGTK stock falls to $0.0009 on PNK Mar 31 2026: what investors should watch
PGTK stock at $0.0009 on PNK (31 Mar 2026). Analysis of drivers, grade, and forecast
CLIQ.TO Alcanna (TSX) C$9.05 intraday 31 Mar 2026: Oversold bounce signals rebound
Intraday oversold bounce on CLIQ.TO stock at C$9.05; technical setup, fundamentals and Meyka AI forecast C$10.50
PEP.SW PepsiCo (SIX) +6.84% after hours 31 Mar 2026: volume spike signals renewed trading interest
PEP.SW stock jumps in after hours on 31 Mar 2026 on a clear volume spike, trading at CHF125.00 with analyst-grade context
Pre-market 4259.T ExaWizards JPY 561.00: AI stocks face valuation test
Pre-market 4259.T stock update: ExaWizards at JPY 561.00, forecasts and Meyka grade for AI stocks
BRAS.CN stock down 50.00% to C$0.005 in market hours: we flag liquidity and valuation risk
BRAS.CN stock drops 50.00% to C$0.005 in market hours; Meyka AI forecast C$3.89 model projection, high liquidity risk
Biogen to Buy Apellis in $5.6 Billion All‑Cash Deal
Biotech giant Biogen announced a major deal to acquire Apellis Pharmaceuticals for $5.6 billion in cash, marking one of the largest strategic transactions in the sector this year. The acquisition is aimed at strengthening Biogen’s drug pipeline, especially in areas such as eye disease and immunology where Apellis has developed promising therapies. Investors reacted strongly…
Centessa Shares Soar Following Lilly’s $6.3B Acquisition Announcement
The stock market reacted strongly after a major acquisition announcement involving Centessa Shares. Eli Lilly, one of the largest pharmaceutical companies in the world, confirmed it will acquire Centessa Pharmaceuticals for $6.3 billion in an all‑cash deal. This news caused Centessa Shares to surge sharply, making the acquisition one of the most talked‑about deals in…